LDS/Medical Tests/Gonadotropin Releasing Hormone (Luteinizing releasing factor)

Gonadotropin Releasing Hormone (Luteinizing releasing factor)

Gonadotropin-Releasing Hormone (GnRH) is a hypothalamic decapeptide hormone crucial for reproductive function. GnRH is secreted in a pulsatile manner by the hypothalamus and regulates the synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from gonadotroph cells in the anterior pituitary gland.

GnRH exerts its biological effects through binding to specific G-protein coupled receptors (GPCRs) on gonadotroph cells, activating the protein kinase C (PKC) pathway, subsequently stimulating synthesis and release of LH and FSH. LH and FSH are essential for normal gonadal development and reproductive functions. In males, LH stimulates Leydig cells to produce testosterone, while FSH acts on Sertoli cells to support spermatogenesis. In females, LH induces ovulation and corpus luteum formation, and FSH promotes ovarian follicular development and estrogen production.

Disruptions in GnRH secretion or its pulsatility can lead to clinical disorders including hypogonadotropic hypogonadism, central precocious puberty, amenorrhea, and polycystic ovary syndrome (PCOS). GnRH analogues are clinically important, used both diagnostically in various reproductive disorders and therapeutically in hormone-dependent cancers such as breast and ovarian malignancies, as well as conditions characterized by hormonal dysregulation.

  • As an aid in the diagnosis of hypogonadism
  • Aid in the investigation and management of infertility and amenorrhea
  • As an aid in the differential diagnosis of polycystic ovary syndrome

Increased levels observed in:

  • Central Precocious Puberty
  • Polycystic Ovary Syndrome (PCOS)
  • Gonadotropin-secreting tumors (e.g., pituitary adenomas)

Decreased levels observed in:

  • Hypogonadotropic Hypogonadism
  • Functional hypothalamic amenorrhea
  • Hyperprolactinemia (due to inhibition of GnRH secretion)

Male: 4.0 – 8.0 pg/mL Female: 2.0 – 10.0 pg/mL

Direct Radioimmunoassay (RIA).

Serum (red top).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7 days
  • Frozen (preferred): 180 days
LH, FSH, progesterone, estradiol, anti-Müllerian hormone (AMH), prolactin, testosterone, thyroid-stimulating hormone (TSH), comprehensive metabolic panel (CMP), semen analysis, androstenedione, sex hormone-binding globulin (SHBG), human chorionic gonadotropin (hCG), complete blood count (CBC), cortisol, and lipid profile.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • South Dartmouth (MA): MDText.com, Inc.; 2000–. [PMID: 25905297]
  • Int J Mol Sci. 2023 Nov 4;24(21):15965. doi: 10.3390 [PMID: 37958948]
  • Hum Reprod Update. 2016 Apr;22(3):358-81. [PMID: 26715597]
  • Endocr J. 2009;56(6):729-37. [PMID: 19609045]
  • Casteel CO, Singh G. Physiology, Gonadotropin-Releasing Hormone. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558992/